RecruitingNot ApplicableNCT02998229
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
Artisse™ Intrasaccular Device IDE
Sponsor
Medtronic Neurovascular Clinical Affairs
Enrollment
300 participants
Start Date
Apr 16, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Artisse™ Intrasaccular Device for people with intracranial aneurysm. The study is currently recruiting participants at 22 locations. People eligible for this study include aged 18 Years to 75 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEArtisse™ Intrasaccular Device
Intrasaccular Device
Locations(25)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02998229
Related Trials
Neurovascular Product Surveillance Registry
NCT0298812899 locations
A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China
NCT07821957
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
NCT072283128 locations
General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter
NCT064166571 location
Product Surveillance Registry
NCT01524276400 locations